| Leuprolide Acetate Injection Rx only | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20260525 | 6 |
| Leuprolide Acetate Injection Rx Only | Sandoz Inc | 20260519 | 24 |
| Leuprolide Acetate Injection Rx only | Eugia US LLC | EUGIA Pharma Specialities Limited | 20260508 | 6 |
| These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | TOLMAR Inc. | 20260430 | 19 |
| Leuprolide Acetate Injection Rx only | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 20260424 | 18 |
| Leuprolide Acetate Injection (leuprolide acetate) (For Subcutaneous Injection) | Avenacy, LLC | 20260413 | 3 |
| Leuprolide Acetate Injection (leuprolide acetate) Rx only | UBI Pharma Inc. | 20260329 | 6 |
| These highlights do not include all the information needed to use CAMCEVI ® safely and effectively. See full prescribing information for CAMCEVI. CAMCEVI (leuprolide) injectable emulsion, for subcutaneous use Initial U.S. Approval: 2021 | Accord BioPharma, Inc. | Fareva Pau | ScinoPharm Taiwan, Ltd. | 20260218 | 8 |
| These highlights do not include all the information needed to use CAMCEVI ® safely and effectively. See full prescribing information for CAMCEVI. CAMCEVI (leuprolide) injectable emulsion, for subcutaneous use Initial U.S. Approval: 2021 | Accord BioPharma, Inc. | Fareva Pau | 20260218 | 9 |
| Leuprolide Acetate Injection Rx only | Zydus Lifesciences Limited | 20260209 | 3 |
| Leuprolide Acetate Injection (leuprolide acetate) Rx only | PAI Holdings, LLC dba PAI Pharma | 20260116 | 4 |
| Leuprolide Acetate Injection [14 mg/2.8 mL (1 mg/0.2 mL)] Rx only | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited | 20251217 | 9 |
| Leuprolide Acetate Injection Rx only | VGYAAN Pharmaceuticals LLC | RK Pharma INC | 20251121 | 7 |
| These highlights do not include all the information needed to use LUPRON DEPOT-PED safely and effectively. See full prescribing information for LUPRON DEPOT-PED. LUPRON DEPOT-PED ® (leuprolide acetate for depot suspension) , for intramuscular use Initial U.S. Approval: 1985 | AbbVie Inc. | 20251114 | 97 |
| These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985 | TOLMAR Inc. | 20250925 | 12 |
| These highlights do not include all the information needed to use LUPRON DEPOT 3.75 mg safely and effectively. See full prescribing information for LUPRON DEPOT 3.75 mg. LUPRON DEPOT 3.75 mg (leuprolide acetate for depot suspension) for injection, for intramuscular use Initial U.S. Approval: 1985 | AbbVie Inc. | 20250918 | 1478 |
| These highlights do not include all the information needed to use LUPRON DEPOT 11.25 mg safely and effectively. See full prescribing information for LUPRON DEPOT 11.25 mg. LUPRON DEPOT 11.25 mg (leuprolide acetate for depot suspension) for injection, for intramuscular use Initial U.S. Approval: 1985 | AbbVie Inc. | 20250910 | 1517 |
| These highlights do not include all the information needed to use LUPRON DEPOT safely and effectively. See full prescribing information for LUPRON DEPOT. LUPRON DEPOT (leuprolide acetate for depot suspension) Initial U.S. Approval: 1989 | AbbVie Inc. | 20250818 | 1542 |
| Leuprolide Acetate Injection Rx only | NorthStar RxLLC | RK Pharma INC | 20250624 | 7 |
| Leuprolide Acetate Injection | Meitheal Pharmaceuticals Inc | 20250616 | 2 |
| These highlights do not include all the information needed to use LUTRATE DEPOT safely and effectively. See full prescribing information for LUTRATE DEPOT. LUTRATE ® DEPOT (leuprolide acetate), for depot suspension Initial U.S. Approval: 2018 | Avyxa Pharma, LLC | 20250603 | 2 |
| These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | URONOVA PHARMACEUTICALS, INC. | 20250601 | 9 |
| These highlights do not include all the information needed to use LEUPROLIDE ACETATE FOR DEPOT SUSPENSION safely and effectively. See full prescribing information for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION. LEUPROLIDE ACETATE FOR DEPOT SUSPENSION. Initial U.S. Approval: 2018 | CIPLA USA INC. | GP PHARM SA | 20240827 | 5 |
| These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985 | TOLMAR Inc. | 20220428 | 17 |
| These highlights do not include all the information needed to use CAMCEVI™ safely and effectively. See full prescribing information for CAMCEVI. CAMCEVI (leuprolide) injectable emulsion, for subcutaneous use Initial U.S. Approval: 2021 | Foresee Pharmaceuticals Co., Ltd. | Pierre Fabre Medicament Production | ScinoPharm Taiwan, Ltd. | 20211115 | 1 |
| These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | TOLMAR Inc. | 20190429 | 51 |
| Viadur ® (leuprolide acetate implant) | Bayer Pharmaceuticals Corporation | 20060510 | 1 |